|
1
|
Glover J, Krailo M, Tello T, Marina N,
Janeway K, Barkauskas D, Fan TM, Gorlick R and Khanna C; COG
Osteosarcoma Biology Group, : A summary of the osteosarcoma banking
efforts: A report from the Children's Oncology Group and the QuadW
Foundation. Pediatr Blood Cancer. 62:450–455. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grignani G, Palmerini E, Ferraresi V,
D'Ambrosio L, Bertulli R, Asaftei SD, Tamburini A, Pignochino Y,
Sangiolo D, Marchesi E, et al: Sorafenib and everolimus for
patients with unresectable high-grade osteosarcoma progressing
after standard treatment: A non-randomised phase 2 clinical trial.
Lancet Oncol. 16:98–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Daw NC, Chou AJ, Jaffe N, Rao BN, Billups
CA, Rodriguez-Galindo C, Meyers PA and Huh WW: Recurrent
osteosarcoma with a single pulmonary metastasis: A
multi-institutional review. Br J Cancer. 112:278–282. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Di Fiore R, Guercio A, Puleio R, Di Marco
P, Drago-Ferrante R, D'Anneo A, De Blasio A, Carlisi D, Di Bella S,
Pentimalli F, et al: Modeling human osteosarcoma in mice through
3AB-OS cancer stem cell xenografts. J Cell Biochem. 113:3380–3392.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moreno F, Cacciavillano W, Cipolla M,
Coirini M, Streitenberger P, López Martí J, Palladino M, Morici M,
Onoratelli M, Drago G, et al: Childhood osteosarcoma: Incidence and
survival in Argentina. Report from the National Pediatric Cancer
Registry, ROHA Network 2000–2013. Pediatr Blood Cancer. 64:2017.
View Article : Google Scholar
|
|
6
|
Durnali A, Alkis N, Cangur S, Yukruk FA,
Inal A, Tokluoglu S, Seker MM, Bal O, Akman T, Inanc M, et al:
Prognostic factors for teenage and adult patients with high-grade
osteosarcoma: An analysis of 240 patients. Med Oncol. 30:6242013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Osborne TS and Khanna C: A review of the
association between osteosarcoma metastasis and protein
translation. J Comp Pathol. 146:132–142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang J, Song W, Tromp G, Kolattukudy PE
and Fu M: Genome-wide survey and expression profiling of CCCH-zinc
finger family reveals a functional module in macrophage activation.
PLoS One. 3:e28802008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang J, Wang J, Azfer A, Song W, Tromp G,
Kolattukudy PE and Fu M: A novel CCCH-zinc finger protein family
regulates proinflammatory activation of macrophages. J Biol Chem.
283:6337–6346. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Minagawa K, Yamamoto K, Nishikawa S, Ito
M, Sada A, Yakushijin K, Okamura A, Shimoyama M, Katayama Y and
Matsui T: Deregulation of a possible tumour suppressor gene,
ZC3H12D, by translocation of IGK@ in transformed follicular
lymphoma with t(2;6)(p12;q25). Br J Haematol. 139:161–163. 2008.
View Article : Google Scholar
|
|
11
|
Huang S, Qi D, Liang J, Miao R, Minagawa
K, Quinn T, Matsui T, Fan D, Liu J and Fu M: The putative tumor
suppressor Zc3h12d modulates toll-like receptor signaling in
macrophages. Cell Signal. 24:569–576. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Wang WC, Chen JK, Zhou L, Wang M,
Wang ZD, Yang B, Xia YM, Lei S, Fu EQ and Jiang T: ZC3H12D
attenuated inflammation responses by reducing mRNA stability of
proinflammatory genes. Mol Immunol. 67:206–212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang M, Vikis HG, Wang Y, Jia D, Wang D,
Bierut LJ, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, et
al: Identification of a novel tumor suppressor gene p34 on human
chromosome 6q25.1. Cancer Res. 67:93–99. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minagawa K, Katayama Y, Nishikawa S,
Yamamoto K, Sada A, Okamura A, Shimoyama M and Matsui T: Inhibition
of G1 to S phase progression by a novel zinc finger
protein P58TFL at P-bodies. Mol Cancer Res. 7:880–889.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nohata N, Hanazawa T, Kikkawa N, Mutallip
M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H,
Nakagawa M, et al: Caveolin-1 mediates tumor cell migration and
invasion and its regulation by miR-133a in head and neck squamous
cell carcinoma. Int J Oncol. 38:209–217. 2011.PubMed/NCBI
|
|
16
|
Chiche J, Pommier S, Beneteau M, Mondragón
L, Meynet O, Zunino B, Mouchotte A, Verhoeyen E, Guyot M, Pagès G,
et al: GAPDH enhances the aggressiveness and the vascularization of
non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.
Leukemia. 29:1163–1176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liberti MV, Dai Z, Wardell SE, Baccile JA,
Liu X, Gao X, Baldi R, Mehrmohamadi M, Johnson MO, Madhukar NS, et
al: A predictive model for selective targeting of the Warburg
effect through GAPDH inhibition with a natural product. Cell Metab.
26:648–659.e8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Révillion F, Pawlowski V, Hornez L and
Peyrat JP: Glyceraldehyde-3-phosphate dehydrogenase gene expression
in human breast cancer. Eur J Cancer. 36:1038–1042. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu LJ and Altmann SW: mRNA and 18S-RNA
coapplication-reverse transcription for quantitative gene
expression analysis. Anal Biochem. 345:102–109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang XJ, Yan ZJ, Luo GC, Chen YY and Bai
PM: miR-26 suppresses renal cell cancer via down-regulating
coronin-3. Mol Cell Biochem. 463:137–146. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bai P, Li W, Wan Z, Xiao Y, Xiao W, Wang
X, Wu Z, Zhang K, Wang Y, Chen B, et al: miR-489-3p inhibits
prostate cancer progression by targeting DLX1. Cancer Manag Res.
12:2719–2729. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu L, Liu S, Duan Q, Chen L, Wu T, Qian
H, Yang S, Xin D, He Z and Guo Y: MicroRNA-142-5p promotes cell
growth and migration in renal cell carcinoma by targeting BTG3. Am
J Transl Res. 9:2394–2402. 2017.PubMed/NCBI
|
|
23
|
Wakahashi S, Kawakami F, Wakahashi K,
Minagawa K, Matsuo K, Katayama Y, Yamada H, Matsui T and Sudo T:
Transformed follicular lymphoma (TFL) predicts outcome in advanced
endometrial cancer. Cancer Epidemiol Biomarkers Prev. 27:963–969.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Z, Ni J, Song D and Ding M: Regulatory
mechanism of microRNA-128 in osteosarcoma tumorigenesis and
evolution by targeting SASH1. Oncol Lett. 15:8687–8694.
2018.PubMed/NCBI
|
|
25
|
Tian Z, Guo B, Yu M, Wang C, Zhang H,
Liang Q, Jiang K and Cao L: Upregulation of micro-ribonucleic
acid-128 cooperating with downregulation of PTEN confers metastatic
potential and unfavorable prognosis in patients with primary
osteosarcoma. Onco Targets Ther. 7:1601–1608. 2014.PubMed/NCBI
|
|
26
|
Liu X, Liang Z, Gao K, Li H, Zhao G, Wang
S and Fang J: MicroRNA-128 inhibits EMT of human osteosarcoma cells
by directly targeting integrin α2. Tumour Biol. 37:7951–7957. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo XL, Wang HB, Yong JK, Zhong J and Li
QH: MiR-128-3p overexpression sensitizes hepatocellular carcinoma
cells to sorafenib induced apoptosis through regulating DJ-1. Eur
Rev Med Pharmacol Sci. 22:6667–6677. 2018.PubMed/NCBI
|
|
28
|
Zhao J, Li D and Fang L: MiR-128-3p
suppresses breast cancer cellular progression via targeting LIMK1.
Biomed Pharmacother. 115:1089472019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang CY, Huang XP, Zhu JY, Chen ZG, Li
XJ, Zhang XH, Huang S, He JB, Lian F, Zhao YN, et al: miR-128-3p
suppresses hepatocellular carcinoma proliferation by regulating
PIK3R1 and is correlated with the prognosis of HCC patients. Oncol
Rep. 33:2889–2898. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Meyers PA, Heller G, Healey JH, Huvos A,
Applewhite A, Sun M and LaQuaglia M: Osteogenic sarcoma with
clinically detectable metastasis at initial presentation. J Clin
Oncol. 11:449–453. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kager L, Zoubek A, Pötschger U, Kastner U,
Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M,
Winkelmann W, et al: Primary metastatic osteosarcoma: Presentation
and outcome of patients treated on neoadjuvant Cooperative
Osteosarcoma Study Group protocols. J Clin Oncol. 21:2011–2018.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim M, Jung JY, Choi S, Lee H, Morales LD,
Koh JT, Kim SH, Choi YD, Choi C, Slaga TJ, et al: GFRA1 promotes
cisplatin-induced chemoresistance in osteosarcoma by inducing
autophagy. Autophagy. 13:149–168. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duan Z, Zhang J, Ye S, Shen J, Choy E,
Cote G, Harmon D, Mankin H, Hua Y, Zhang Y, et al: A-770041
reverses paclitaxel and doxorubicin resistance in osteosarcoma
cells. BMC Cancer. 14:6812014. View Article : Google Scholar : PubMed/NCBI
|
